![[Adobe Stock]](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_750,h_375/https://www.psypost.org/wp-content/uploads/2025/04/psychedelic-head-750x375.jpg)
Occasional use of classic psychedelics like LSD and psilocybin is not associated with cognitive decline and might actually be linked to better mental adaptability. A recent evaluation of young adults found that sporadic users performed as well as non-users on a variety of brain function tests, while exhibiting a distinct advantage in shifting problem-solving strategies. The research was published in Progress in Neuropsychopharmacology & Biological Psychiatry.
Classic psychedelics alter perception and mood by interacting with specific brain receptors. Examples include psilocybin, which is the active compound in magic mushrooms, and LSD. Clinical trials are testing these substances as treatments for mental health conditions, prompting increased public interest. At the same time, recreational use of these compounds is rising across the globe.
Past research regarding the long-term cognitive effects of psychedelics has yielded conflicting results. Early studies exploring LSD and mescaline in the middle of the twentieth century raised alarms about potential brain damage. However, these older investigations often suffered from small sample sizes or failed to account for outside factors that can warp test results.
More recent research looking at the frequent, ritualistic consumption of peyote or the Amazonian brew ayahuasca pointed to neutral outcomes. Some studies even hinted at slight benefits in memory and problem-solving. Ritualistic use typically happens within well-defined cultural frameworks that tightly regulate the dosage and context of the psychedelic experience.
Lead author Simon Reiche, a researcher at Charité in Berlin, Germany, and his colleagues identified a gap in the literature. Most people around the world who consume psychedelics do so sporadically in unstructured, naturalistic settings. The research team wanted to investigate whether these mild to moderate use patterns left any lasting marks on cognitive health.
To find out, the researchers recruited 136 participants between the ages of 18 and 50. The study group included 84 individuals who had used psychedelics at least once in their lives and 52 control subjects who had never tried them. The participants underwent structured psychiatric evaluations and screening to ensure they had abstained from all psychoactive substances for two weeks prior to testing.
The researchers administered a comprehensive battery of neuropsychological tests. These assessments measured multiple domains of brain function. The specific areas included attention, memory, visuospatial abilities, and executive functioning.
Executive functioning is a broad term for the advanced mental skills that help people plan, focus their attention, remember instructions, and juggle multiple tasks successfully. Working memory and impulse control fall under this operational umbrella. These skills are required for navigating daily challenges and achieving long-term goals.
Recognizing that people who take psychedelics routinely consume other substances, the researchers allowed participants with mild use of other recreational drugs into the study. To make the groups as comparable as possible, they required the control subjects to have a history of cannabis use. This rule was established because cannabis consumption was common among the psychedelic users.
The research team also conducted a more refined comparison using a statistical technique called matched-pair analysis. They isolated 30 participants from the psychedelic group who had used the drugs more than ten times in their lives. They then paired these individuals with 30 control subjects who shared similar age, sex, education levels, and cannabis habits.
When looking at the entire study population, the researchers observed that overall cognitive performance was broadly equivalent between the two groups. The individuals who used psychedelics showed no signs of overall cognitive deterioration. Across basic tests for memory, processing speed, and attention, the scores lined up closely with those of the non-users.
The matched-pair analysis revealed a pronounced difference in one specific area of executive functioning. The psychedelic users demonstrated a clear advantage on the Wisconsin Card Sorting Test. This particular assessment measures cognitive flexibility, which is the brain’s ability to adapt its behavior and thoughts in response to changing situations.
During the Wisconsin Card Sorting Test, participants are asked to sort cards based on hidden rules that change without warning as the test progresses. The subject must figure out the new rule through trial and error. The psychedelic users made fewer repetitive mistakes than the control subjects. They were less likely to stick to an old sorting strategy after it stopped working.
The researchers also looked for a dose-response relationship within the overall group of psychedelic users. They analyzed whether the amount of lifetime psychedelic use correlated with test performance. They found an association between a higher number of past psychedelic experiences and fewer errors on the card sorting test.
Other analyses within the study supported these observations. When adjusting for variables like education and alcohol use, the researchers noticed that lifetime psychedelic use was tied to quicker visual reaction times during a divided attention task. In this task, participants had to monitor visual and auditory signals simultaneously. This suggests an overlap between problem-solving adaptability and the ability to allocate attention effectively in a dynamic setting.
Cognitive flexibility plays a central role in complex decision-making and the capacity to devise fresh strategies when confronted with unfamiliar scenarios. Mental rigidity, the opposing trait, is a hallmark of several psychiatric conditions. These inflexible thought patterns play heavily into substance abuse, eating disorders, and severe depression.
The observed association with mental flexibility aligns with emerging theories about how psychedelics affect the physical brain. Recent biological studies suggest these compounds promote structural changes in neurons. They are chemically thought to induce a temporary window of elevated neuroplasticity.
Neuroplasticity refers to the central nervous system’s ability to reorganize its structure, functions, or connections in response to internal or external stimuli. Psychedelics exert their influence by activating specific serotonin receptors distributed throughout the cerebral cortex. This activation triggers chemical cascades inside the cells that can lead to subtle structural alterations.
Scientists have observed that these chemical compounds encourage the branching of dendrites in animal models. Dendrites act as the communication antennas on nerve cells. By encouraging the growth of new connections between brain cells, psychedelics might facilitate an unconstrained state of cognition.
The study has several limitations that prevent the researchers from declaring that psychedelics directly cause increases in cognitive flexibility. Because the research relied on a cross-sectional design, it only captured a snapshot in time. It is possible that individuals who possess naturally high levels of mental flexibility are more drawn to experimenting with psychedelics in the first place.
The study also relied on self-reported data regarding past substance use. Asking participants to recall specific drug events from years past introduces the possibility of memory biases or inaccurate reporting. Additionally, the psychedelic users in the matched group had higher rates of lifetime use of other illicit substances, which could have influenced the test scores.
Despite the statistical matching process, the study population largely consisted of highly educated, urban young adults. This demographic profile reflects broader trends in non-clinical psychedelic use, but it limits how well the findings apply to differing populations. The researchers noted that the chemical purity and dosage of the street drugs consumed by the participants could not be independently verified.
The researchers also evaluated multiple variables without making targeted statistical adjustments that penalize for multiple comparisons. This mathematical approach increases the risk that some of the favorable test results occurred by chance alone. To confirm these initial observations, future research will need to employ focused, long-term cognitive evaluations.
Advancing the scientific understanding of these substances will require extensive studies that track individuals before and after they start using psychedelics. The researchers hope their work will inform realistic risk profiles for evolving public health initiatives. By investigating non-medical drug use in realistic settings, scientists can better grasp the true biological effects of these potent compounds.
The study, “Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis,” was authored by Simon Reiche, Tim Hirschfeld, Anna Lena Gröticke, Marie Traub, Nicklas Jakob Hafiz, Rico Haas, Lara Sedlaczek, Linda Ortlieb, Georg Leistenschneider, Lukas A. Basedow, Andrea Lohse, Felix Bermpohl, Thomas Günther Riemer, and Tomislav Majić.
